Abstract
This article reviews recent literature on phototherapy for psoriasis, particularly narrowband UVB. The efficacy, safety, tolerability and acceptance of phototherapy are discussed.
It focuses in detail on how to improve the efficacy and safety in practice by trying to optimize the protocols, using combination therapy, monitoring the cumulative dose and providing skin cancer suirveillance. Careful pacient selection, individualized treatment, long-therapy plan and complex approach to patiens are the prerequisities for this.
Narrowband UVB as the most widely used modality has a relatively good efficacy, cost, avaibility and minimal side effects. It represents a valuable treatment which deserves more utilization and research.
Even in the era of biologics phototherapy remains an important therapeutic modality for psoriasis and other dermatoses and represents an essentials part of modern dermatological therapy